Isentress (raltegravir) is a new HIV drug in Canada

Isentress (raltegravir) is a new HIV drug in Canada.

It's the first in a new class called integrase inhibitors.

HIV integrase is one of three enzymes needed by HIV to reproduce. Older drugs block either of the other two enzymes...reverse transcriptase or protease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote